Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM—CP): a study protocol

Rosalind Adam* (Corresponding Author), Saravanakumar Kanakarajan, Uzunma Onyeakazi, Malachy Columb, Helen Galley

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Downloads (Pure)

Fingerprint Dive into the research topics of 'Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM—CP): a study protocol'. Together they form a unique fingerprint.

Medicine & Life Sciences